GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
The COVID-19 pandemic increased social isolation and stress—affecting the behavioral health of many Americans. Data suggests higher rates of anxiety and depression symptoms, and more substance use among many adults, as a result.
The Office of National Drug Control Policy (ONDCP) coordinates the nation's drug control policy. ONDCP's responsibilities include tracking and publicizing information about federal grants that fund drug control activities, such as prevention and treatment.
The CARES Act requires GAO to look at the government's response to the COVID-19 pandemic, including vaccine development. Vaccines prepare the body to respond quickly to an infection and play a key role in keeping people and global communities healthy.
When COVID-19 vaccines became available, the federal government sent most doses to states to distribute but also set up its own vaccine distribution programs.
State and local health officials said the federal programs helped higher-risk groups get vaccinated.
People from various racial and ethnic groups may experience health disparities—preventable differences in health outcomes. Discrimination, economic instability, and lack of health care access are some of the factors that can contribute to these disparities.